Głuchowska Małgorzata, Paradowska-Stankiewicz Iwona
Zakład Epidemiologii, Narodowego Instytutu Zdrowia Publicznego - Państwowego, Zakładu Higieny w Warszawie.
Przegl Epidemiol. 2012;66(2):191-5.
Despite of the decline in the incidence rate of mumps which is the main result of the modifications of the Polish Immunization Programme (the vaccination against mumps has become obligatory since 2003), it is still a disease which occurs frequently in children.
The main objective of the present article was to analyze the epidemiological situation of mumps in Poland in 2010 in comparison with the data from previous year. This paper was based on aggregated data published in "Infectious diseases and poisonings in Poland in 2010", "Vaccinations in Poland in 2010", "Case definitions for the infectious diseases used for the surveillance purposes in 2009-2011" and Polish Immunization Programme for 2010.
In Poland in 2010, 2 754 cases of mumps were reported. The incidence rate was 7.2 per 100 000 and was lower in comparison with the incidence rate observed in 2009 (7.7) and five times lower than the median incidence reported in 2004-2008. The highest incidence rate was observed in the children aged 5-9 years (53.9). Thirty two out of2 574 notified cases were hospitalized (1.16%).
Realization of the vaccination against mumps using conjugate MMR (measles-mumps-rubella) vaccine contributed to the decrease in the incidence rate of mumps in Polish population. The high vaccination coverage implies that the incidence rate of mumps will be still decreasing.
尽管波兰免疫规划的调整使腮腺炎发病率有所下降(自2003年起腮腺炎疫苗接种成为强制性),但它仍是儿童中常见的疾病。
本文的主要目的是将2010年波兰腮腺炎的流行病学情况与上一年的数据进行比较。本文基于《2010年波兰传染病和中毒情况》《2010年波兰疫苗接种情况》《2009 - 2011年用于监测目的的传染病病例定义》以及2010年波兰免疫规划中公布的汇总数据。
2010年波兰报告了2754例腮腺炎病例。发病率为每10万人7.2例,与2009年观察到的发病率(7.7)相比有所降低,且比2004 - 2008年报告的发病率中位数低五倍。5 - 9岁儿童的发病率最高(53.9)。在2574例报告病例中,有32例住院(1.16%)。
使用结合型MMR(麻疹 - 腮腺炎 - 风疹)疫苗进行腮腺炎疫苗接种有助于降低波兰人群中腮腺炎的发病率。高疫苗接种覆盖率意味着腮腺炎发病率仍将下降。